Actions of estrogens on glial cells: Implications for neuroprotection

Biochimica et Biophysica Acta - General Subjects

Volumn 1800, Issue 10, 2010, Pages 1106-1112

  Arevalo, María Angeles ^a   Santos Galindo, María ^a   Bellini, María José ^a   Azcoitia, Iñigo ^b   Garcia Segura, Luis M ^a  

^a INSTITUTO CAJAL   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Astroglia; Estradiol; Microglia; Myelin; Oligodendroglia; Selective estrogen receptor modulator

Indexed keywords

BAZEDOXIFENE; ESTRADIOL; ESTROGEN; FULVESTRANT; GLUTAMIC ACID; GROWTH FACTOR; MYELIN; OSPEMIFENE; PROGESTERONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; UNCLASSIFIED DRUG; WAY 138923; NEUROPROTECTIVE AGENT; SIGNAL PEPTIDE;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; BRAIN EDEMA; BRAIN INJURY; CELL SURVIVAL; CELL TYPE; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG MEGADOSE; EDEMA; ENCEPHALITIS; ESTROGEN ACTIVITY; ESTROGEN THERAPY; GLIA CELL; HORMONE ACTION; HUMAN; INFLAMMATION; MACROGLIA; MICROGLIA; MOOD DISORDER; NERVE CELL; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REMYELINIZATION; REVIEW; SCHWANN CELL; TISSUE LEVEL; ANIMAL; ASTROCYTE; BIOSYNTHESIS; BRAIN INJURIES; DRUG EFFECTS; METABOLISM; MYELIN SHEATH;

ANIMALS; ASTROCYTES; BRAIN EDEMA; BRAIN INJURIES; CELL SURVIVAL; ESTROGENS; GLUTAMIC ACID; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROGLIA; MYELIN SHEATH; NEURONS; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA;

EID: 77956179368     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.10.002     Document Type: Review

References (143)

1. Garcia-Segura L.M. Hormones and Brain Plasticity 2009, Oxford University Press, New York.
2. The Tripartite Synapse-Glia in Synaptic Transmission 2002, Oxford University Press. A. Volterra, P.J. Magistretti, P.G. Haydon (Eds.).
3. Verkhratsky A., Butt A. Glial Neurobiology; a Textbook 2007, Wiley Publishers, Hoboken, NJ.
4. Shumaker S.A., Legault C., Rapp S.R., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289:2651-2662.
5. Wassertheil-Smoller S., Hendrix S.L., Limacher M., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003, 289:2673-2684.
6. Yaffe K. Hormone therapy and the brain: deja vu all over again?. JAMA 2003, 289:2717-2719.
7. Doncarlos L.L., Azcoitia I., Garcia-Segura L.M. Neuroprotective actions of selective estrogen receptor modulators. Psychoneuroendocrinology 2010, 34:S113-S122.
8. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 2001, 63:29-60.
9. Morissette M., Al Sweidi S., Callier S., Di Paolo T. Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol. Cell. Endocrinol. 2008, 290:60-69.
10. Vegeto E., Benedusi V., Maggi A. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative disease. Front. Neuroendocrinol. 2008, 29:507-519.
11. Simpkins J.W., Yi K.D., Yang S.H. Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens. Front. Neuroendocrinol. 2009, 30:93-105.
12. Suzuki S., Brown C.M., Wise P.M. Neuroprotective effects of estrogens following ischemic stroke. Front. Neuroendocrinol. 2009, 30:201-211.
13. Dhandapani K.M., Brann D.W. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol. Reprod. 2002, 67:1379-1385.
14. Murphy S., McCullough L., Littleton-Kearney M., Hurn P. Estrogen and selective estrogen receptor modulators: neuroprotection in the Women's Health Initiative era. Endocrine 2003, 21:17-26.
15. Zhao L., O'Neill K., Diaz Brinton R. Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Res. Brain Res. Rev. 2005, 49:472-493.
16. Garcia-Ovejero D., Azcoitia I., Doncarlos L.L., Melcangi R.C., Garcia-Segura L.M. Glia-Neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res. Brain Res. Rev. 2005, 48:273-286.
17. Blurton-Jones M. M.H. Tuszynski, Reactive astrocytes express estrogen receptors in the injured primate brain. J. Comp. Neurol. 2001, 433:115-123.
18. Savaskan E., Olivieri G., Meier F., Ravid R., Müller-Spahn F. Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease. Brain Res. 2001, 908:113-119.
19. García-Ovejero D., Veiga S., García-Segura L.M., Doncarlos L.L. Glial expression of estrogen and androgen receptors after rat brain injury. J. Comp. Neurol. 2002, 450:256-271.
20. Lu Y.P., Zeng M., Hu X.Y., Xu H., Swaab D.F., Ravid R., Zhou J.N. Estrogen receptor alpha-immunoreactive astrocytes are increased in the hippocampus in Alzheimer's disease. Exp. Neurol. 2003, 183:482-488.
21. Takahashi N., Tonchev A.B., Koike K., Murakami K., Yamada K., Yamashima T., Inoue M. Expression of estrogen receptor-beta in the postischemic monkey hippocampus. Neurosci. Lett. 2004, 369:9-13.
22. Sakuma S., Tokuhara D., Hattori H., Matsuoka O., Yamano T. Expression of estrogen receptor alpha and beta in reactive astrocytes at the male rat hippocampus after status epilepticus. Neuropathology 2009, 29:55-62.
23. Carbonaro V., Caraci F., Giuffrida M.L., et al. Enhanced expression of ERalpha in astrocytes modifies the response of cortical neurons to beta-amyloid toxicity. Neurobiol. Dis. 2009, 33:415-421.
24. Hirahara Y., Matsuda K., Gao W., Arvanitis D.N., Kawata M., Boggs J.M. The localization and non-genomic function of the membrane-associated estrogen receptor in oligodendrocytes. Glia 2009, 57:153-165.
25. Kuo J., Hariri O.R., Bondar G., Ogi J., Micevych P. Membrane estrogen receptor-alpha interacts with metabotropic glutamate receptor type 1a to mobilize intracellular calcium in hypothalamic astrocytes. Endocrinology 2009, 150:1369-1376.
26. Ivanova T., Karolczak M., Beyer C. Estrogen stimulates the mitogen-activated protein kinase pathway in midbrain astroglia. Brain Res. 2001, 889:264-269.
27. Zhang L., Li B., Zhao W., et al. Sex-related differences in MAPKs activation in rat astrocytes: effects of estrogen on cell death. Brain Res. Mol. Brain Res. 2002, 103:1-11.
28. Dhandapani K.M., Wade F.M., Mahesh V.B., Brann D.W. Astrocyte-derived transforming growth factor-β mediates the neuroprotective effects of 17β-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology 2005, 146:2749-2759.
29. Chaban V.V., Lakhter A.J., Micevych P. A membrane estrogen receptor mediates intracellular calcium release in astrocytes. Endocrinology 2004, 145:3788-3795.
30. Arnold S. Estrogen suppresses the impact of glucose deprivation on astrocytic calcium levels and signaling independently of the nuclear estrogen receptor. Neurobiol. Dis. 2005, 20:82-92.
31. Wang J.Y., Wen L.L., Huang Y.N., Chen Y.T., Ku M.C. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr. Pharm. Des. 2006, 12:3521-3533.
32. Fawcett J.W., Keynes R.J. Peripheral nerve regeneration. Annu. Rev. Neurosci. 1990, 13:43-78.
33. Chen Z.L., Yu W.M., Strickland S. Peripheral regeneration. Annu. Rev. Neurosci. 2007, 30:209-233.
34. Franklin R.J., Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 2008, 9:839-855.
35. Azcoitia I., Sierra A., Veiga S., Garcia-Segura L.M. Aromatase expression by reactive astroglia is neuroprotective. Ann. N. Y. Acad. Sci. 2003, 1007:298-305.
36. Garcia-Segura L.M., Veiga S., Sierra A., Melcangi R.C., Azcoitia I. Aromatase: a neuroprotective enzyme. Prog. Neurobiol. 2003, 71:31-41.
37. Saldanha C.J., Duncan K.A., Walters B.J. Neuroprotective actions of brain aromatase. Front. Neuroendocrinol. 2009, 30:106-118.
38. Laird M.D., Vender J.R., Dhandapani K.M. Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 2008, 16:154-164.
39. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 11:1387-1394.
40. Curry J.J., Heim L.M. Brain myelination after neonatal administration of oestradiol. Nature 1966, 209:915-916.
41. Jung-Testas I., Schumacher M., Bugnard H., Baulieu E.E. Stimulation of rat Schwann cell proliferation by estradiol: synergism between estrogen and cAMP. Dev. Brain Res. 1993, 72:282-290.
42. Svenningsen A.F., Kanje M. Estrogen and progesterone stimulate Schwann cell proliferation in a sex- and age-dependent manner. J. Neurosci. Res. 1999, 57:124-130.
43. Marin-Husstege M., Muggirioni M., Raban D., Skoff R.P., Casaccia-Bonnefil P. Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones. Dev. Neurosci. 2004, 26:245-254.
44. Jung-Testas I., Renoir M., Bugnard H., Greene G.L., Baulieu E.E. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J. Steroid Biochem. Mol. Biol. 1992, 41:621-631.
45. Bourdeau V., Deschênes J., Métivier R., Nagai Y., Nguyen D., Bretschneider N., Gannon F., White J.H., Mader S. Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol. Endocrinol. 2004, 18:1411-1427.
46. Zhu T.S., Glaser M. Neuroprotection and enhancement of remyelination by estradiol and dexamethasone in cocultures of rat DRG neurons and Schwann cells. Brain Res. 2008, 1206:20-32.
47. Offner H., Polanczyk M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann. N. Y. Acad. Sci. 2006, 1089:343-372.
48. Kipp M., Beyer C. Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis. Front. Neuroendocrinol. 2009, 30:188-200.
49. Gerstner B., Sifringer M., Dzietko M., et al. Estradiol attenuates hyperoxia-induced cell death in the developing white matter. Ann. Neurol. 2007, 61:562-573.
50. Gerstner B., Lee J., DeSilva T.M., Jensen F.E., Volpe J.J., Rosenberg P.A. 17Beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J. Neurosci. Res. 2009, 87:2078-2086.
51. Acs P., Kipp M., Norkute A., et al. 17Beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 2009, 57:807-814.
52. Morales L.B., Loo K.K., Liu H.B., Peterson C., Tiwari-Woodruff S., Voskuhl R.R. Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J. Neurosci. 2006, 26:6823-6833.
53. Garay L., Gonzalez Deniselle M.C., Gierman L., et al. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 2008, 15:76-83.
54. Tiwari-Woodruff S., Voskuhl R.R. Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice. J. Neurol. Sci. 2009, 286:81-85.
55. Elloso M.M., Phiel K., Henderson R.A., Harris H.A., Adelman S.J. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands. J. Endocrinol. 2005, 185:243-252.
56. Bebo B.F., Dehghani B., Foster S., Kurniawan A., Lopez F.J., Sherman L.S. Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis. Glia 2009, 57:777-790.
57. Tranque P.A., Suarez I., Olmos G., Fernandez B., Garcia-Segura L.M. Estradiol-induced redistribution of glial fibrillary acidic protein immunoreactivity in the rat brain. Brain Res. 1987, 406:348-351.
58. Luquin S., Naftolin F., Garcia-Segura L.M. Natural fluctuation and gonadal hormone regulation of astrocyte immunoreactivity in dentate gyrus. J. Neurobiol. 1993, 24:913-924.
59. Garcia-Segura L.M., Chowen J.A., Parducz A., Naftolin F. Gonadal hormones as promoters of structural synaptic plasticity: cellular mechanisms. Prog. Neurobiol. 1994, 44:279-307.
60. Garcia-Segura L.M., Chowen J.A., Naftolin F. Endocrine glia: roles of glial cells in the brain actions of steroid and thyroid hormones and in the regulation of hormone secretion. Front. Neuroendocrinol. 1996, 17:180-211.
61. Mong J.A., Blutstein T. Estradiol modulation of astrocytic form and function: implications for hormonal control of synaptic communication. Neuroscience 2006, 138:967-975.
62. McCarthy M.M. Estradiol and the developing brain. Physiol. Rev. 2008, 88:91-124.
63. Stone D.J., Rozovsky I., Morgan T.E., Anderson C.P., Hajain H., Finch C.E. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp. Neurol. 1997, 143:313-318.
64. Mydlarski M.B., Liberman A., Schipper H.M. Estrogen induction of glial heat shock proteins: implications for hypothalamic aging. Neurobiol. Aging 1995, 16:977-981.
65. Lu A., Ran R.Q., Clark J., Reilly M., Nee A., Sharp F.R. 17-Beta-estradiol induces heat shock proteins in brain arteries and potentiates ischemic heat shock protein induction in glia and neurons. J. Cereb. Blood Flow Metab. 2002, 22:183-195.
66. Tomas-Camardiel M., Venero J.L., Herrera A.J., et al. Blood-Brain barrier disruption highly induces aquaporin-4 mRNA and protein in perivascular and parenchymal astrocytes: protective effect by estradiol treatment in ovariectomized animals. J. Neurosci. Res. 2005, 80:235-246.
67. Pawlak J., Brito V., Kuppers E., Beyer C. Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res. Mol. Brain Res. 2005, 138:1-7.
68. Karakaya S., Kipp M., Beyer C. Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system. J. Neuroendocrinol. 2007, 19:682-690.
69. Ma Y.J., Berg-von der Emde K., Moholt-Siebert M., Hill D.F., Ojeda S.R. Region specific regulation of transforming growth factor alpha (TGFα) gene expression in astrocytes of the neuroendocrine brain. J. Neurosci 1994, 14:5644-5651.
70. Galbiati M., Martini L., Melcangi R.C. Oestrogens, via transforming growth factor a, modulate basic fibroblast growth factor synthesis in hypothalamic astrocytes: in vitro observations. J. Neuroendocrinol. 2002, 14:829-835.
71. Buchanan C.D., Mahesh V.B., Brann D.W. Estrogen-Astrocyte-Luteinizing hormone-releasing hormone signaling: a role for transforming growth factor βv1. Biol. Reprod. 2000, 62:1710-1721.
72. Melcangi R.C., Cavarretta I., Magnaghi V., Martini L., Galbiati M. Interactions between growth factors and steroids in the control of LHRH neurons. Brain Res. Brain Res. Rev. 2001, 37:223-234.
73. Zwain I.H., Arroyo A., Amato P., Yen S.S. A role for hypothalamic astrocytes in dehydroepiandrosterone and estradiol regulation of gonadotropin-releasing hormone (GnRH) release by GnRH neurons. Neuroendocrinol 2002, 75:375-383.
74. Sortino M.A., Chisari M., Merlo S., et al. Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death. Endocrinology 2004, 145:5080-5086.
75. Garcia-Segura L.M., McCarthy M.M. Minireview: role of glia in neuroendocrine function. Endocrinology 2004, 145:1082-1086.
76. Soucy G., Boivin G., Labrie F., Rivest S. Estradiol is required for a proper immune response to bacterial and viral pathogens in the female brain. J. Immunol. 2005, 174:6391-6398.
77. Cerciat M., Unkila M., Garcia-Segura L.M., Arevalo M.A. Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro. Glia 2010, 58:93-102.
78. Araújo G.W., Beyer C., Arnold S. Oestrogen influences on mitochondrial gene expression and respiratory chain activity in cortical and mesencephalic astrocytes. J. Neuroendocrinol. 2008, 20:930-941.
79. Sinchak K., Mills R.H., Tao L., LaPolt P., Lu J.K., Micevych P. Estrogen induces de novo progesterone synthesis in astrocytes. Dev. Neurosci. 2003, 25:343-348.
80. Mahesh V.B., Dhandapani K.M., Brann D.W. Role of astrocytes in reproduction and neuroprotection. Mol. Cell Endocrinol. 2006, 246:1-9.
81. Garcia-Segura L.M., Lorenz B., DonCarlos L.L. The role of glia in the hypothalamus: implications for gonadal steroid feedback and reproductive neuroendocrine output. Reproduction 2008, 135:419-429.
82. Micevych P., Sinchak K. Estradiol regulation of progesterone synthesis in the brain. Mol. Cell Endocrinol. 2008, 290:44-50.
83. Garcia-Segura L.M., Chowen J.A., Duenas M., Torres-Aleman I., Naftolin F. Gonadal steroids as promoters of neuro-glial plasticity. Psychoneuroendocrinology 1994, 19:445-453.
84. Garcia-Segura L.M., Luquin S., Parducz A., Naftolin F. Gonadal hormone regulation of glial fibrillary acidic protein immunoreactivity and glial ultrastructure in the rat neuroendocrine hypothalamus. Glia 1994, 10:59-69.
85. McCarthy J.B., Barker-Gibb A.L., Alves S.E., Milner T.A. TrkA immunoreactive astrocytes in dendritic fields of the hippocampal formation across estrous. Glia 2002, 38:36-44.
86. Cambiasso M.J., Colombo J.A., Carrer H.F. Differential effect of oestradiol and astroglia-conditioned media on the growth of hypothalamic neurons from male and female rat brains. Eur. J. Neurosci. 2000, 12:2291-2298.
87. Rozovsky I., Wei M., Stone D.J., et al. Estradiol (E2) enhances neurite outgrowth by repressing glial fibrillary acidic protein expression and reorganizing laminin. Endocrinology 2002, 143:636-646.
88. Barreto G., Veiga S., Azcoitia I., Garcia-Segura L.M., Garcia-Ovejero D. Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. Eur. J. Neurosci. 2007, 25:3039-3046.
89. Garcia-Estrada J., Del Rio J.A., Luquin S., Soriano E., Garcia-Segura L.M. Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury. Brain Res. 1993, 628:271-278.
90. Garcia-Estrada J., Luquin S., Fernandez A., Garcia-Segura L.M. Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury. Int. J. Dev. Neurosci. 1999, 17:145-151.
91. Ciriza I., Carrero P., Azcoitia I., Lundeen S.G., Garcia-Segura L.M. Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol. J. Neurobiol. 2004, 61:209-221.
92. Tripanichkul W., Sripanichkulchai K., Finkelstein D.I. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication. Brain Res. 2006, 1064:28-37.
93. Martinez L., de Lacalle S. Astrocytic reaction to a lesion, under hormonal deprivation. Neurosci. Lett. 2007, 415:190-193.
94. Lei D.L., Long J.M., Hengemihle J., et al. Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice. Neuroscience 2003, 121:659-666.
95. Saravia F., Beauquis J., Pietranera L., De Nicola A.F. Neuroprotective effects of estradiol in hippocampal neurons and glia of middle age mice. Psychoneuroendocrinology 2007, 32:480-492.
96. Ritz M.F., Hausmann O.N. Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats. Brain Res. 2008, 1203:177-188.
97. Lewis D.K., Johnson A.B., Stohlgren S., Harms A., Sohrabji F. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. J. Neuroimmunol. 2008 Mar, 195(1-2):47-59.
98. Liang Z., Valla J., Sefidvash-Hockley S., Rogers J., Li R. Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J. Neurochem. 2002, 80:807-814.
99. Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007, 28:138-145.
100. van Heteren J.T., Rozenberg F., Aronica E., Troost D., Lebon P., Kuijpers T.W. Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in Aicardi-Goutieres syndrome. Glia 2008, 56:568-578.
101. Dong Y., Benveniste E.N. Immune function of astrocytes. Glia 2001, 36:180-190.
102. Rebenko-Moll N.M., Liu L., Cardona A., Ransohoff R.M. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr. Opin. Immunol. 2006, 18:683-689.
103. Rostene W., Kitabgi P., Parsadaniantz S.M. Chemokines: a new class of neuromodulator?. Nat. Rev. Neurosci. 2007, 8:895-903.
104. Kipp M., Karakaya S., Johann S., Kampmann E., Mey J., Beyer C. Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumour necrosis factor-alpha and interleukin-18 in midbrain astrocytes. J. Neuroendocrinol. 2007, 19:819-822.
105. Tenenbaum M., Azab A.N., Kaplanski J. Effects of estrogen against LPS-induced inflammation and toxicity in primary rat glial and neuronal cultures. J. Endotoxin Res. 2007, 13:158-166.
106. Dodel R.C., Du Y., Bales K.R., Gao F., Paul S.M. Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A beta(1-40) and lipopolysaccharides. J. Neurochem. 1999, 73:1453-1460.
107. Park C., Lee S., Cho I.H., et al. TLR3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression. Glia 2006, 53:248-256.
108. Lin S.T., Wang Y., Xue Y., Feng D.C., Xu Y., Xu L.Y. Tetrandrine suppresses LPS-induced astrocyte activation via modulating IKKs-IkappaBalpha-NF-kappaB signaling pathway. Mol. Cell Biochem. 2008, 315:41-49.
109. Sato K., Saito Y., Oka J., Ohwada T., Nakazawa K. Effects of tamoxifen on l-glutamate transporters of astrocytes. J. Pharmacol. Sci. 2008, 107:226-230.
110. Ghisletti S., Meda C., Maggi A., Vegeto E. 17{beta}-Estradiol inhibits inflammatory gene expression by controlling NF-{kappa}B intracellular localization. Mol. Cell. Biol. 2005, 25:957-968.
111. Thomas W.E. Brain macrophages: evaluation of microglia and their functions. Brain Res. Brain Res. Rev. 1992, 17:61-74.
112. Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Prog. Neurobiol. 1999, 57:563-581.
113. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 2005, 18:315-321.
114. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
115. Bruce-Keller A.J., Keeling J.L., Keller J.N., Huang F.F., Camondola S., Mattson M.P. Anti-inflammatory effects of estrogen on microglial activation. Endocrinology 2000, 141:3646-3656.
116. Drew P.D., Chavis J.A. Female sex steroids: effects upon microglial cell activation. J. Neuroimmunol. 2000, 111:77-85.
117. Bruce-Keller A.J., Barger S.W., Moss N.I., Pham J.T., Keller J.N., Nath A. Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17 beta-estradiol. J. Neurochem. 2001, 78:1315-1324.
118. Vegeto E., Bonincontro C., Pollio G., et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 2001, 21:1809-1818.
119. Baker A.E., Brautigam V.M., Watters J.J. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 2004, 145:5021-5032.
120. Dimayuga F.O., Reed J.L., Carnero G.A., et al. Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines. J. Neuroimmunol. 2005, 161:123-136.
121. Vegeto E., Belcredito S., Etteri S., et al. Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9614-9619.
122. Vegeto E., Belcredito S., Ghisletti S., Meda C., Etteri S., Maggi A. The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 2006, 147:2263-2272.
123. Tapia-Gonzalez S., Carrero P., Pernia O., Garcia-Segura L.M., Diz-Chaves Y. Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs. J. Endocrinol. 2008, 198:219-230.
124. Li R., Shen Y., Yang L.B., Lue L.F., Finch C., Rogers J. Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex. J. Neurochem. 2000, 75:1447-1454.
125. Yue X., Lu M., Lancaster T., et al. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:19198-19203.
126. Sierra A., Gottfried-Blackmore A., Milner T.A., McEwen B.S., Bulloch K. Steroid hormone receptor expression and function in microglia. Glia 2008, 56:659-674.
127. Suuronen T., Nuutinen T., Huuskonen J., Ojala J., Thornell A., Salminen A. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells. Inflamm. Res. 2005, 54:194-203.
128. Barreto G., Santos-Galindo M., Diz-Chaves Y., et al. Selective estrogen receptor modulators decrease reactive astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones. Endocrinology 2009, 150:5010-5015.
129. Suzuki S., Brown C.M., Dela Cruz C.D., Yang E., Bridwell D.A., Wise P.M. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6013-6018.
130. Maki P.M. A systematic review of clinical trials of hormone therapy on cognitive function: effects of age at initiation and progestin use. Ann. N. Y. Acad. Sci. 2005, 1052:182-197.
131. Miller V.M., Clarkson T.B., Harman S.M., et al. Women, hormones, and clinical trials: a beginning, not an end. J. Appl. Physiol. 2005, 99:381-383.
132. Nordell V., Scarborough M., Buchanan A., Sohrabji F. Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals. Neurobiol. Aging 2003, 5798:1-11.
133. Johnson A., Sohrabji F. Estrogen's effects on central and circulating immune cells vary with reproductive age. Neurobiol. Aging 2005, 26:1365-1374.
134. Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007, 28:521-574.
135. Rao S.P., Sikdar S.K. Acute treatment with 17beta-estradiol attenuates astrocyte-astrocyte and astrocyte-neuron communication. Glia 2007, 55:1680-1689.
136. Thi A.D., Jung-Testas I., Baulieu E.E. Neuronal signals are required for estrogen-mediated induction of progesterone receptor in cultured rat Schwann cells. J. Steroid Biochem. Mol. Biol. 1998, 67:201-211.
137. Stone D.J., Song Y., Anderson C.P., Krohn K.K., Finch C.E., Rozovsky I. Bidirectional transcription regulation of glial fibrillary acidic protein by estradiol in vivo and in vitro. Endocrinology 1998, 139:3202-3209.
138. Garcia-Segura L.M., Cañas B., Parducz A., et al. Estradiol promotion of astroglial cell shape changes depends on the expression of polysisalic acid on neuronal membranes. Glia 1995, 13:209-216.
139. Mong J.A., Nunez J.L., McCarthy M.M. GABA mediates steroid-induced astrocyte differentiation in the neonatal rat hypothalamus. J. Neuroendocrinol. 2002, 14:45-55.
140. De Nicola A.F., Gonzalez S.L., Labombarda F., et al. Progesterone treatment of spinal cord injury: effects on receptors, neurotrophins, and myelination. J. Mol. Neurosci. 2006, 28:3-15.
141. De Nicola A.F., Labombarda F., Deniselle M.C., et al. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front. Neuroendocrinol. 2009, 30:173-187.
142. Gulinello M., Etgen A.M. Sexually dimorphic hormonal regulation of the gap junction protein, CX43, in rats and altered female reproductive function in CX43+/- mice. Brain Res. 2005, 1045:107-115.
143. Stirone C., Duckles S.P., Krause D.N. Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E184-E192.